Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Other ETFs median (248 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 26 Aug 2022 – 20 Aug 2026, limited by Motilal Oswal BSE Quality ETF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Motilal Oswal BSE Quality ETF | Nifty 500 |
|---|---|---|
| 26 Aug 2022 | ₹100.00 | ₹100.00 |
| 25 Dec 2022 | ₹101.97 | ₹99.33 |
| 26 Apr 2023 | ₹103.25 | ₹98.99 |
| 25 Aug 2023 | ₹115.97 | ₹111.05 |
| 24 Dec 2023 | ₹136.08 | ₹125.79 |
| 23 Apr 2024 | ₹152.58 | ₹136.34 |
| 23 Aug 2024 | ₹187.49 | ₹154.60 |
| 22 Dec 2024 | ₹162.01 | ₹147.35 |
| 22 Apr 2025 | ₹157.57 | ₹145.80 |
| 21 Aug 2025 | ₹167.46 | ₹152.75 |
| 21 Dec 2025 | ₹171.99 | ₹156.31 |
| 21 Apr 2026 | ₹176.25 | ₹152.12 |
| 20 Aug 2026 | ₹176.67 | ₹155.23 |
| Metric | Motilal Oswal NAV ₹203.31 Very High risk ★★★☆☆ | Category median Other ETFs · 248 funds |
|---|---|---|
| +5.18% | +3.65% | |
| +15.16% | +10.51% | |
| — | +9.28% | |
| — | +11.93% | |
| +15.36% | +10.38% | |
| +11.37% | — | |
| +17.30% | +14.30% | |
| — | +13.74% | |
| — | +12.83% | |
| Risk | ||
| 14.99% | 15.45% | |
| 0.58 | 0.28 | |
| 0.80 | 0.41 | |
| -24.63% | -20.59% | |
| Nifty 500 | — | |
| +2.96% | +0.80% | |
| 1.05 | 1.00 | |
| 111.8% | 102.1% | |
| 100.8% | 96.4% | |
| 0.54% | 0.32% | |
| ₹25.47Cr | ₹137.31Cr | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| Rakesh Shetty | — | |
| 26 Aug 2022 | — | |
| 30 | — | |
| 56.3% | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.